ArticleTobacco induced diseases2025
Impact of tobacco exposure on global deaths of digestive diseases: Findings from 1990-2021 and projected trends to 2042.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tobacco-driven digestive disease burden: A China-US comparative analysis, 1990-2035.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTobacco exposure is a leading modifiable risk factor for preventable deaths, harming the digestive system, and leading to a large number of deaths.
methodsA secondary assessment of Global Burden of Disease (GBD) datasets was conducted. From 1990 to 2021, data on deaths from tobacco exposure on digestive diseases, including various genders and age groups, from the 2021 GBD Study were utilized. Trends across 204 countries/territories, 21 GBD, and 5 sociodemographic index (SDI) regions were analyzed. Additionally, a detailed analysis was conducted. Pearson correlation analysis, frontier analysis, age-period-cohort (APC) model, and the Bayesian APC (BAPC) model was utilized.
resultsFrom 1990 to 2021, the global number of deaths from tobacco-attributable digestive diseases decreased from 52789 (95% uncertainty interval (UI): 36999-68307) to 34061 (95% UI: 23821-46548). The age-standardized rate also decreased, from 1.34 (95% UI: 0.93-1.73) to 0.40 (95% UI: 0.28-0.55). Overall, SDI was negatively associated with disease burden, and the Quality of Care Index for digestive diseases increased with SDI. Results from the APC analysis showed that the mortality rate increased with age; more recently born cohorts had lower mortality rates at the same age; and the mortality rate across all age groups decreased over time. Predictions indicated that the death burden of tobacco-attributable digestive diseases will continue to decline for both males and females from 2022 to 2042.
conclusionsGlobal tobacco-attributable digestive diseases mortality may have decreased due to tobacco control and medical advances. The disease burden in older adults, males, and regions with middle to high SDI deserves special attention. Countries with a relatively high disease burden should learn from those with a lower burden among nations at the same SDI level regarding tobacco control and healthcare management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.